Macrophages in Renal Injury, Repair, Fibrosis Following Acute Kidney Injury and Targeted Therapy
- PMID: 35911736
- PMCID: PMC9326079
- DOI: 10.3389/fimmu.2022.934299
Macrophages in Renal Injury, Repair, Fibrosis Following Acute Kidney Injury and Targeted Therapy
Abstract
Acute kidney injury (AKI) is a renal disease with a high incidence and mortality. Currently, there are no targeted therapeutics for preventing and treating AKI. Macrophages, important players in mammalian immune response, are involved in the multiple pathological processes of AKI. They are dynamically activated and exhibit a diverse spectrum of functional phenotypes in the kidney after AKI. Targeting the mechanisms of macrophage activation significantly improves the outcomes of AKI in preclinical studies. In this review, we summarize the role of macrophages and the underlying mechanisms of macrophage activation during kidney injury, repair, regeneration, and fibrosis and provide strategies for macrophage-targeted therapies.
Keywords: fibrosis; inflammation; kidney; macrophages; regeneration; repair; therapy.
Copyright © 2022 Chen, Liu and Zhuang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Macrophage-driven inflammation in acute kidney injury: Therapeutic opportunities and challenges.Transl Res. 2025 Apr;278:1-9. doi: 10.1016/j.trsl.2025.02.003. Epub 2025 Feb 13. Transl Res. 2025. PMID: 39954848 Review.
-
CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C+ M2-like macrophage infiltration.Int Immunopharmacol. 2020 Nov;88:106854. doi: 10.1016/j.intimp.2020.106854. Epub 2020 Aug 6. Int Immunopharmacol. 2020. PMID: 32771945
-
The role of macrophages during acute kidney injury: destruction and repair.Pediatr Nephrol. 2019 Apr;34(4):561-569. doi: 10.1007/s00467-017-3883-1. Epub 2018 Jan 30. Pediatr Nephrol. 2019. PMID: 29383444 Free PMC article. Review.
-
Macrophages in Renal Injury and Repair.Annu Rev Physiol. 2017 Feb 10;79:449-469. doi: 10.1146/annurev-physiol-022516-034219. Annu Rev Physiol. 2017. PMID: 28192060 Review.
-
Biology of renal recovery: molecules, mechanisms, and pathways.Nephron Clin Pract. 2014;127(1-4):10-4. doi: 10.1159/000363714. Epub 2014 Sep 24. Nephron Clin Pract. 2014. PMID: 25343813 Free PMC article. Review.
Cited by
-
The role of macrophages in renal fibrosis and therapeutic prospects.PeerJ. 2025 Jul 23;13:e19769. doi: 10.7717/peerj.19769. eCollection 2025. PeerJ. 2025. PMID: 40718783 Free PMC article. Review.
-
Intracellular iron accumulation throughout the progression of sepsis influences the phenotype and function of activated macrophages in renal tissue damage.Front Physiol. 2025 Jan 30;16:1430946. doi: 10.3389/fphys.2025.1430946. eCollection 2025. Front Physiol. 2025. PMID: 39949667 Free PMC article.
-
Identification of Hub Genes Correlated with the Initiation and Progression of CKD in the Unilateral Ureteral Obstruction Model.Biomedicines. 2025 May 27;13(6):1316. doi: 10.3390/biomedicines13061316. Biomedicines. 2025. PMID: 40564035 Free PMC article.
-
Mechanism of Astragaloside IV in Treatment of Renal Tubulointerstitial Fibrosis.Chin J Integr Med. 2025 May;31(5):474-480. doi: 10.1007/s11655-024-3805-6. Epub 2024 Jun 8. Chin J Integr Med. 2025. PMID: 38850482 Review.
-
Yuanhuacine modulates lipopolysaccharide-induced interleukin-6 through regulation of the JAK1/STAT3 pathway and prevents tubular damage in acute kidney injury.Exp Ther Med. 2025 Jul 3;30(3):168. doi: 10.3892/etm.2025.12918. eCollection 2025 Sep. Exp Ther Med. 2025. PMID: 40692765 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources